Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-21-007027

President and CEO sold 18,334 shares at an average $68.44 ($1,254,819)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Watts Ryan J. President and CEO 2021-02-01 Sale −14,222 $68.21 $970,111 2,308,761 I: show line 1 in the form
Watts Ryan J. President and CEO 2021-02-01 Sale −3,552 $69.17 $245,681 2,305,209 I: show line 2 in the form
Watts Ryan J. President and CEO 2021-02-01 Sale −560 $69.69 $39,026 2,304,649 I: show line 3 in the form
Open-market sales · 18,334 sh · avg $68.44 · $1,254,819
Loading xslF345X03/doc4.xml…